Identification of the sensory nerve fiber responsible for lysophosphatidic acid-induced allodynia in mice

Neuroscience

Volumn 247, Issue , 2013, Pages 65-74

  Ohsawa, M ^a   Miyabe, Y ^a   Katsu, H ^a   Yamamoto, S ^a   Ono, H ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Lysophosphatidic acid (LPA); Mechanical allodynia; Myelinated A fiber; Neurometer test; TRPV1

Indexed keywords

LYSOPHOSPHATIDIC ACID; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

AFFERENT NERVE GROUP 1; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROSTIMULATION; HYPERALGESIA; MOUSE; MYELINATED NERVE; NERVE FIBER A BETA; NERVE FIBER A DELTA; NERVE FIBER C; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; SPINAL GANGLION;

DORSAL ROOT GANGLION; DRG; LPA; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID (LPA); MECHANICAL ALLODYNIA; MYELINATED A FIBER; NEUROMETER TEST; PBS; PHOSPHATE-BUFFERED SALINE; RESINIFERATOXIN; RTX; TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 1; TRPV1; TRPV1 IMMUNOREACTIVITY; TRPV1-IR;

ANIMALS; ELECTRIC STIMULATION; HOT TEMPERATURE; HYPERALGESIA; LYSOPHOSPHOLIPIDS; MICE; NERVE FIBERS; NERVE FIBERS, UNMYELINATED; PAIN MEASUREMENT; PHYSICAL STIMULATION; SENSORY RECEPTOR CELLS; TRPV CATION CHANNELS;

EID: 84879255844     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.05.014     Document Type: Article

References (34)

1. Bridges D., Thompson S.W., Rice A.S. Mechanisms of neuropathic pain. Br J Anaesth 2001, 87:12-26.
2. Campbell J.N., Raja S.N., Meyer R.A., Mackinnon S.E. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 1988, 32:89-94.
3. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63.
4. Dixon W.J. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462.
5. Fujita R., Kiguchi N., Ueda H. LPA-mediated demyelination in ex vivo culture of dorsal root. Neurochem Int 2007, 50:351-355.
6. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 1988, 32:77-88.
7. Hylden J.L., Wilcox G.L. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980, 67:313-316.
8. Inoue M., Rashid M.H., Fujita R., Contos J.J.A., Chun J., Ueda H. Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling. Nature Med 2004, 10:712-718.
9. Inoue M., Yamaguchi A., Kawakami M., Chun J., Ueda H. Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain. Mol Pain 2006, 2:25.
10. Jefferys J.G.R. Nonsynaptic modulation of neuronal activity in the brain: electric currents and extracellular ions. Physiol Rev 1995, 75:689-723.
11. Katims J.J. Neuroselective current perception threshold quantitative sensory test. Muscle Nerve 1997, 20:1468-1469.
12. Koga K., Furue H., Rashid M.H., Takaki A., Katafuchi T., Yoshimura M. Selective activation of primary afferent fibers evaluated by sine-wave electrical stimulation. Mol Pain 2005, 1:13.
13. Koltzenburg M., Torebjörk H.E., Wahren L.K. Nociceptor modulated central sensitization causes mechanical hyperalgesia in acute chemogenic and chronic neuropathic pain. Brain 1994, 117:579-591.
14. Kunde D.A., Crawford A., Geraghty D.P. Tachykinin (NK1, NK2 and NK3) receptor, transient receptor potential vanilloid 1 (TRPV1) and early transcription factor, cFOS, mRNA expression in rat tissues following systemic capsaicin treatment. Regul Pept 2013, 183C:35-41.
15. Lengyel C., Torok T., Varkonyi T., Kempler P., Rudas L. Baroreflex sensitivity and heart-rate variability in insulin-dependent diabetics with polyneuropathy. Lancet 1998, 351:1436-1437.
16. Lin M.E., Herr D.R., Chun J. Lysophosphatidic acid (LPA) receptors. Signaling properties and disease relevance. Prostaglandins Other Lipid Mediat 2010, 91:130-138.
17. Lin M.E., Rivera R.R., Chun J. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain. J Biol Chem 2012, 287:17608-17617.
18. Ma L., Matsumoto M., Xie W., Inoue M., Ueda H. Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist. J Neurochem 2009, 109:603-610.
19. Ma L., Uchida H., Nagai J., Inoue M., Chun J., Aoki J., Ueda H. Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: an initiator of nerve injury-induced neuropathic pain. Mol Pain 2009, 5:64.
20. Matsumoto M., Inoue M., Hald A., Xie W., Ueda H. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 2006, 318:735-740.
21. Matsumoto M., Xie W., Ma L., Ueda H. Pharmacological switch in Aβ-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury. Mol Pain 2008, 4:25.
22. Noguchi K., Herr D., Mutoh T., Chun J. Lysophosphatidic acid (LPA) and its receptors. Curr Opin Pharmacol 2009, 9:15-23.
23. Pan H.L., Khan G.M., Alloway K.D., Chen S.R. Resiniferatoxin induces paradoxical changes in thermal and mechanical sensitivities in rats: mechanism of action. J Neurosci 2003, 23:2911-2919.
24. Pan H.L., Zhang Y.Q., Zhao Z.Q. Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCε pathway in dorsal root ganglion neurons. Mol Pain 2010, 6:85.
25. Pitei D.L., Watkins P.J., Stevens M.J., Edmonds M.E. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994, 11:872-876.
26. Rashid M.H., Inoue M., Bakoshi S., Ueda H. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropathic pain in mice. J Pharmacol Exp Ther 2003, 306:709-717.
27. Rashid M.H., Inoue M., Kondo S., Kawashima T., Bakoshi S., Ueda H. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 2003, 304:940-948.
28. Rivera R., Chun J. Biological effects of lysophospholipids. Rev Physiol Biochem Pharmacol 2008, 160:25-46.
29. Sandkühler J. Models and mechanisms of hyperalgesia and allodynia. Physiol Rev 2009, 89:707-758.
30. Schoffnegger D., Ruscheweyh R., Sandkühler J. Spread of excitation across modality borders in spinal dorsal horn of neuropathic rats. Pain 2008, 135:300-310.
31. Sheen K., Chung J.M. Signs of neuropathic pain depend on signals from injured fibers in a rat model. Brain Res 1993, 610:62-68.
32. Ueda H. Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms. Pharmacol Ther 2006, 109:57-77.
33. Woolf C.J. Molecular signals responsible for the reorganization of the synaptic circuitry of the dorsal horn after peripheral nerve injury: the mechanisms of tactile allodynia. Molecular neurobiology of pain 1997, 171-200. IPAS, Seattle, WA. D. Borsook (Ed.).
34. Yoon Y.W., Na H.S., Chung J.M. Contributions of injured and intact afferents to neuropathic pain in an experimental rat model. Pain 1996, 64:27-36.